Healthcare Worker Responsibilities
MDR Article 14 โ Your Hospital's Legal Obligations
Under MDR, hospitals that purchase and use medical devices have specific legal obligations โ these are not optional best practices
MDR Article 14 โ In Plain Language
When a hospital buys and supplies a medical device to its staff or patients, it acts as a distributor under MDR. This means it must verify that CE marking is present, check EUDAMED for safety alerts, forward complaints to manufacturers, and cooperate with corrective actions. These are organisational responsibilities โ but frontline staff play a key role in making them work in practice.
Verify CE Marking
Before a device enters the hospital supply chain, it must bear a valid CE mark and a Declaration of Conformity must be available. If a device arrives without CE marking, it should be quarantined and reported to procurement.
Forward Complaints
If a healthcare worker or patient reports a complaint about a device โ even if no harm occurred โ the hospital must pass that complaint to the manufacturer or authorised representative. Do not filter complaints yourself.
Check EUDAMED
Hospitals should check the European database on medical devices (EUDAMED) for Field Safety Corrective Actions and safety alerts. In practice, clinical engineering or procurement typically monitors EUDAMED, but staff should be aware it exists.
Cooperate with Corrective Actions
When a manufacturer issues a recall, software update, or modified instruction, the hospital must cooperate fully. This means acting on Field Safety Notices promptly and confirming actions taken back to the manufacturer.
Your Individual Obligations
What MDR expects of you personally โ not just your hospital
MDR Article 87(10)
Healthcare professionals are empowered under MDR to report serious incidents directly to the HPRA. You do not always need to wait for a manager or clinical engineer to do this for you โ especially if there is any risk of delay.
Observe & Recognise
Be alert to any device that does not perform as intended, causes unexpected reactions, or shows signs of deterioration. If something feels wrong, it probably warrants investigation.
Ensure Patient Safety
Your first action is always to make the patient safe. Remove the device from use if it can be done safely. Provide any necessary clinical intervention.
Preserve the Device
Do not discard, clean, or return the device to the manufacturer before it has been inspected. Quarantine it with all packaging, accessories, and labelling intact.
Document What Happened
Record the device name, manufacturer, UDI/lot number, what happened, when, the patient outcome, and who was involved. Include photographs if appropriate.
Report Through NIMS
Use the National Incident Management System (NIMS) to log the event. Also inform your line manager and clinical engineering department.
Cooperate with Investigations
The manufacturer, HPRA, or your clinical engineering team may ask follow-up questions. Provide factual, accurate information about what you observed.
Act on Field Safety Notices
When clinical engineering or procurement forwards a Field Safety Notice (FSN), take the specified action โ whether that is removing devices from use, applying a software update, or changing how you use a device.
Understanding Incident Types
MDR defines specific categories โ knowing the difference determines how quickly you should report
Incident
Any malfunction, deterioration in characteristics or performance, or inadequacy in the information supplied by the manufacturer that, directly or indirectly, might lead to or might have led to harm.
- โข Use-error caused by ergonomic design features
- โข Inadequacy in manufacturer labelling or instructions for use
- โข Undesirable side-effects not listed in IFU
- โข Deterioration in performance (e.g. reduced battery life, sensor drift)
Serious Incident
Any incident that directly or indirectly led to, might have led to, or might lead to:
- โข Death of a patient, user, or other person
- โข Temporary or permanent serious deterioration of health
- โข A serious public health threat
- โข Hospitalisation or prolongation of existing hospitalisation
- โข Medical or surgical intervention to prevent any of the above
๐ Trend Reporting โ MDR Article 88
Even if individual incidents seem minor, a pattern of similar events across multiple patients or over time may trigger trend reporting obligations. For example, if several patients report unexpected skin reactions from the same wound dressing batch, the manufacturer must assess whether these events together represent a statistically significant increase in severity or frequency โ and report accordingly. Your individual report may be the one that reveals a trend.
๐ก When in Doubt โ Report
Under-reporting is a far greater risk than over-reporting. The HPRA and the manufacturer's vigilance team determine final severity classification โ your job is to accurately document and promptly report what you observed. If you are uncertain whether something counts as an incident, report it anyway.
What Happens After You Report
The incident lifecycle does not end when you submit a report โ here is what happens next
1. HPRA Receives Your Report
Once reported through NIMS or directly, the HPRA receives the information and logs it in their vigilance system. They assess the report to determine if it meets the definition of a serious incident.
2. Manufacturer Investigation (MDR Article 89)
The manufacturer must investigate without delay and perform a risk assessment. They submit an initial report to the HPRA within regulated timelines:
2 days
Serious public health threat
10 days
Death or serious deterioration
15 days
All other serious incidents
3. Corrective Action (FSCA) if Needed
If the investigation confirms a safety issue, the manufacturer issues a Field Safety Corrective Action (FSCA) โ which may involve a device recall, modification, software update, or revised instructions for use. They must also issue a Field Safety Notice (FSN) to all affected users.
4. Feedback to Reporting Hospital
The HPRA monitors the manufacturer's investigation and may communicate outcomes back through the vigilance system. Your clinical engineering department should receive and distribute relevant safety updates. If you reported directly, you may receive feedback through your hospital's quality department.
๐ HPRA Contact Information
Phone (vigilance queries):
01 676 4971
Online reporting portal:
hpra.ie โ Report a ProblemUDI & Device Traceability
The Unique Device Identifier (UDI) system and why recording it matters
MDR Article 27
For Class III implantable devices, recording the UDI is a legal requirement โ not just good practice. This is what makes targeted recalls possible. If a manufacturer discovers a defect in a specific production batch, the UDI allows them to identify exactly which hospitals received those devices and which patients were implanted.
๐
Record the UDI
Scan or manually record the UDI barcode from the device label into the patient record and asset register
๐ฆ
Check Lot/Serial
Verify the lot or serial number matches what was supplied and is traceable in your hospital's inventory system
๐
Enable Recall Response
Accurate UDI recording means your hospital can respond to targeted recalls quickly โ identifying affected patients within hours
Device Use Obligations in Daily Practice
MDR does not just apply when things go wrong โ there are ongoing obligations every time you use, procure, or receive a medical device
โ Before Using Any Device
- โข Check that the device bears a valid CE mark
- โข Verify that instructions for use (IFU) are available in English
- โข Confirm you have received appropriate training
- โข Check the expiry date and inspect packaging integrity
- โข For single-use devices โ do not reuse; if your hospital policy allows reprocessing under Article 17, consult clinical engineering
๐ฆ When Receiving Devices
- โข Verify delivery against purchase order โ correct device, quantity, and specification
- โข Inspect packaging for damage or signs of tampering
- โข Check that storage conditions were maintained during transit (e.g. cold chain for temperature-sensitive devices)
- โข Record the UDI, lot number, and expiry date in your asset management system
๐ง Maintenance & Storage
- โข Store devices according to the manufacturer's specifications (temperature, humidity, light exposure)
- โข Follow the manufacturer's maintenance schedule โ do not modify maintenance intervals
- โข Ensure calibration is current for devices that require it
- โข Keep maintenance logs accessible for audit and inspection
๐ซ Off-Label Use
- โข Using a device outside its intended purpose (off-label) is not covered by the CE marking
- โข If a clinician decides off-label use is clinically justified, this decision must be documented
- โข The hospital assumes responsibility for patient safety in off-label scenarios
- โข Consult your clinical engineering department and risk manager before off-label use
Responding to Field Safety Notices (FSNs)
When a manufacturer identifies a safety issue, they issue an FSN โ here is what you need to do
A Field Safety Notice is a communication sent by the manufacturer to users and customers about a Field Safety Corrective Action (FSCA). Your response depends on the type of FSCA specified:
Device Recall
Remove specified devices from use, quarantine them, and return as directed by the manufacturer. Record which units were removed and which patients may have been exposed.
Modified Use Instructions
Update your practice according to the revised IFU. Ensure all staff who use the device are informed of the change. Document the update.
Software Update
Coordinate with clinical engineering to apply the update. Do not use the device until the update is confirmed. Verify functionality after update.
Labelling Correction
Replace affected labels or packaging. Ensure the corrected information is accessible to all users. Update any local reference documents.
๐ฏ Key Takeaways
MDR Article 14 places legal obligations on hospitals that act as distributors โ CE marking verification, complaint forwarding, and EUDAMED checks are organisational responsibilities.
You are empowered by MDR Article 87(10) to report serious incidents directly to the HPRA โ you do not always need to wait for a manager to do so.
The full incident reporting process has 7 steps โ most training covers only 4. Steps 5โ7 (HPRA notification, investigation cooperation, and receiving feedback) are equally important.
After you report, the manufacturer must investigate within regulated timelines (2, 10, or 15 days depending on severity). If a safety issue is confirmed, they must issue an FSN and take corrective action.
UDI recording is not just good practice โ for Class III implantable devices, it is a legal requirement under MDR Article 27 and HSE guidance.
When in doubt, report. Under-reporting is a greater risk than over-reporting. The HPRA and manufacturer determine severity โ your job is to document and report promptly.
Irish Context โ Your Reporting Obligations
Under MDR Article 14, healthcare professionals in Ireland must report serious incidents involving medical devices to the HPRA using their online reporting portal.
The HPRA defines a reportable incident as one where a device has caused or could have caused death, serious deterioration in health, or a serious public health threat.
HSE hospitals typically have an internal incident reporting coordinator who liaises with the HPRA. Report internally first, but ensure the HPRA notification is made within the required timelines.
The HPRA also operates a Vigilance team (Tel: +353 1 676 4971) for urgent device safety queries.
Useful HPRA Links:
This is educational content only and is not an accredited or externally verified course. Always refer to official HPRA publications and your facility's own policies.
Knowledge Check
6 questions ยท 80% required to pass
Q1.Under MDR Article 14, when a hospital purchases and supplies medical devices, it is treated as a distributor. Which of the following is NOT one of the hospital's legal obligations in this role?
Q2.A nurse discovers that an infusion pump has malfunctioned during a procedure but no patient harm occurred. Under MDR, what is the correct course of action?
Q3.MDR Article 87(10) empowers healthcare professionals in which specific way?
Q4.After a serious incident is reported, the manufacturer must investigate and submit an initial report to the HPRA. What are the regulated timelines for this initial report?
Q5.A manufacturer issues a Field Safety Corrective Action (FSCA) requiring a software update on a patient monitoring device used in your ward. What should you do?
Q6.A colleague tells you informally that a wound dressing they have been using caused unexpected skin reactions in several patients last week, but they did not report it. Under MDR, what is the correct position?
0/6 answered
Print-Friendly Summary
One-page PDF for ward reference & quick revision
Was this module useful?